Doctor Philippe Rouet
Rangueil Hospital of Toulouse, Toulouse (France)
sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure, independent of Mineralocorticoid Receptor Antagonists treatment.
Event: Heart Failure 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome
A single systemic injection of AAV9-hIGFBP2 prevents left ventricular hypertrophy and dysfunction in metabolic syndrome
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Gene and cell therapy
Session: Basic science - Gene and cell therapy - Cytokines and inflammation - Molecular biology - Genetics
